Home › Funds › Catalio Capital Management, LP › FTH
Catalio Capital Management, LP position in FTH
FAETH THERAPEUTICS INC
Catalio Capital Management, LP reported holding 14,718 shares of FTH (FAETH THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$368K, representing 0.07% of its reported portfolio and ranking #39 among its reported holdings. Catalio Capital Management, LP has disclosed FTH holdings in 5 of the last 5 reported quarters, going back to Q2 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Catalio Capital Management, LP's FTH position evolved
Catalio Capital Management, LP first disclosed a stake in FTH in Q2 2025 at 14,718 shares (US$126K). The position peaked in Q1 2026 at 14,718 shares, worth US$464K. Across 5 filings, Catalio Capital Management, LP held the position steady without any share-count change. The most recent filing (Q2 2026) shows 14,718 shares valued at US$368K.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 14.72K | $126.28K | New |
| Q3 2025 | 14.72K | $139.09K | Hold |
| Q4 2025 | 14.72K | $157.04K | Hold |
| Q1 2026 | 14.72K | $463.91K | Hold |
| Q2 2026 | 14.72K | $367.95K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About FTH and 13F data
FTH (FAETH THERAPEUTICS INC) is a company whose sector is not yet classified in our data. 46 other funds we track also report a position in FTH — the largest reported positions include MONTANOVA CAPITAL, LLC (US$50.5M), Avoro Capital Advisors LLC (US$36.1M), BAKER BROS. ADVISORS LP (US$32.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding FTH
- MONTANOVA CAPITAL, LLC 2.02M sh · $50.50M · Q2 2026
- Avoro Capital Advisors LLC 1.44M sh · $36.10M · Q2 2026
- BAKER BROS. ADVISORS LP 1.29M sh · $32.16M · Q2 2026
- Fairmount Funds Management LLC 722.02K sh · $18.05M · Q2 2026
- Logos Global Management LP 722.02K sh · $18.05M · Q2 2026
- Vivo Capital, LLC 722.02K sh · $18.05M · Q2 2026
- Caligan Partners LP 629.47K sh · $15.74M · Q2 2026
- B Group, Inc. 610.17K sh · $15.25M · Q2 2026
- Trails Edge Capital Partners, LP 515.34K sh · $12.88M · Q2 2026
- Octagon Capital Advisors LP 361.01K sh · $9.03M · Q2 2026
- Cormorant Asset Management, LP 1.03M sh · $7.66M · Q2 2026
- Boxer Capital Management, LLC 180.50K sh · $4.51M · Q2 2026
More on Catalio Capital Management, LP
FAQ
How long has Catalio Capital Management, LP held FTH?
Catalio Capital Management, LP has disclosed FTH holdings in 5 of the last 5 reported quarters, going back to Q2 2025.
What is Catalio Capital Management, LP's current position in FTH?
As of Q2 2026, Catalio Capital Management, LP holds 14.72K shares of FTH (FAETH THERAPEUTICS INC), valued at $367.95K, representing 0.07% of its reported portfolio and ranking #39.
Has Catalio Capital Management, LP been buying or selling FTH?
In the latest 13F filing (Q2 2026), Catalio Capital Management, LP held unchanged its position in FTH. The position peaked in Q1 2026 at 14.72K shares.
Which other funds hold FTH?
Other major institutional holders of FTH include MONTANOVA CAPITAL, LLC, Avoro Capital Advisors LLC, BAKER BROS. ADVISORS LP, among 46 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.